Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $1.25 Million - $1.58 Million
5,902 New
5,902 $1.27 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $1.77 Million - $2.44 Million
-9,074 Reduced 60.11%
6,022 $1.61 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $937,512 - $1.11 Million
4,999 Added 49.51%
15,096 $3.08 Million
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $1.89 Million - $2.38 Million
9,758 Added 2878.47%
10,097 $2.13 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $4.93 Million - $6.34 Million
-22,020 Reduced 98.48%
339 $81,000
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $1.89 Million - $2.46 Million
6,679 Added 42.6%
22,359 $6.33 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $4.06 Million - $6.5 Million
15,680 New
15,680 $5.43 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $447,028 - $523,719
-1,840 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $434,718 - $654,359
1,840 New
1,840 $451,000
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $2.04 Million - $2.35 Million
-7,699 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $1.83 Million - $2.42 Million
7,079 Added 1141.77%
7,699 $2.06 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $194,647 - $246,912
-724 Reduced 53.87%
620 $196,000
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $241,845 - $334,172
1,099 Added 448.57%
1,344 $399,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $53,272 - $59,750
245 New
245 $57,000
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $27,849 - $30,698
-127 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $27,522 - $43,047
127 New
127 $30,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $26,415 - $34,544
-90 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $75,453 - $89,924
-293 Reduced 76.5%
90 $26,000
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $99,629 - $140,909
383 New
383 $105,000
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $29,841 - $33,424
-97 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $27,271 - $31,979
97
97 $30,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.